New U.K. trial tests mixing COVID-19 vaccines

A new study in the U.K. is examining the efficacy of mixing COVID-19 vaccine doses from different manufacturers. The trial will begin with one dose of the Oxford-AstraZeneca shot followed by the Pfizer-BioNTech shot.